Bayer CropScience Limited (BOM:506285)

Bayer CropScience Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	4,784	14,146	8,855	11,568	8,608	7,809
Trading Asset Securities	-	574	354	539	411	385
Cash & Short-Term Investments	5,423	14,720	9,209	12,107	9,019	8,194
Cash Growth	-23.26%	59.84%	-23.94%	34.24%	10.07%	-34.80%
Accounts Receivable	18,198	11,155	9,521	9,601	9,756	10,047
Other Receivables	-	85	52	60	39	98
Receivables	18,198	11,240	9,573	9,661	9,795	10,145
Inventory	20,649	21,355	23,618	15,452	18,072	15,120
Prepaid Expenses	-	83	70	68	67	113
Other Current Assets	3,399	1,785	2,246	1,767	2,011	2,183
Total Current Assets	47,669	49,183	44,716	39,055	38,964	35,755
Property, Plant & Equipment	3,942	4,064	4,274	3,826	4,313	4,504
Other Intangible Assets	1,516	1,553	1,364	1,254	1,147	893
Long-Term Deferred Tax Assets	159	124	97	-	-	73
Other Long-Term Assets	2,086	2,070	2,008	1,836	2,362	2,304
Total Assets	55,372	56,994	52,459	45,971	46,786	43,529

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	7,046	12,379	10,984	6,051	8,732	8,198
Accrued Expenses	899	1,801	1,225	1,003	1,510	1,354
Current Portion of Leases	342	430	435	261	371	346
Current Income Taxes Payable	547	45	17	19	29	159
Current Unearned Revenue	-	3,130	3,424	2,851	2,866	2,431
Other Current Liabilities	13,292	7,890	6,152	5,789	4,267	4,105
Total Current Liabilities	22,126	25,675	22,237	15,974	17,775	16,593
Long-Term Leases	362	388	616	210	364	518
Pension & Post-Retirement Benefits	-	373	253	402	713	400
Long-Term Deferred Tax Liabilities	-	-	-	40	3	-
Other Long-Term Liabilities	1,041	901	849	851	810	775
Total Liabilities	23,529	27,337	23,955	17,477	19,665	18,286

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	449	449	449	449	449	449
Additional Paid-In Capital	-	1,394	1,394	1,394	1,394	1,394
Retained Earnings	-	27,762	26,609	26,599	25,226	23,348
Comprehensive Income & Other	31,394	52	52	52	52	52
Shareholders' Equity	31,843	29,657	28,504	28,494	27,121	25,243
Total Liabilities & Equity	55,372	56,994	52,459	45,971	46,786	43,529

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	704	818	1,051	471	735	864
Net Cash (Debt)	4,719	13,902	8,158	11,636	8,284	7,330
Net Cash Growth	-21.96%	70.41%	-29.89%	40.46%	13.01%	-40.43%
Net Cash Per Share	105.00	309.33	181.52	258.91	184.33	163.10
Filing Date Shares Outstanding	44.94	44.94	44.94	44.94	44.94	44.94
Total Common Shares Outstanding	44.94	44.94	44.94	44.94	44.94	44.94
Working Capital	25,543	23,508	22,479	23,081	21,189	19,162
Book Value Per Share	708.52	659.89	634.24	634.02	603.47	561.68
Tangible Book Value	30,327	28,104	27,140	27,240	25,974	24,350
Tangible Book Value Per Share	674.78	625.34	603.89	606.11	577.94	541.81
Land	-	350	350	307	307	307
Buildings	-	2,531	2,377	2,362	2,381	2,312
Machinery	-	3,474	3,345	3,243	3,271	3,042
Construction In Progress	-	49	5	64	29	133

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error